Search
Search Constraints
You searched for: Is Part Of Cancer. Volume 126:Issue 2(2020)Limit your search
- 616.99405 32
- Cancer -- Cytopathology -- Periodicals 32
- Cancer -- Periodicals 32
- AURA3 -- circulating tumor DNA (ctDNA) -- epidermal growth factor receptor (EGFR) mutation -- epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) -- non–small cell lung cancer (NSCLC) -- osimertinib -- plasma -- T790M -- tissue 1
- BRCA testing -- breast cancer -- mutation carrier -- ovarian cancer -- pathogenic variant carrier -- primary prevention -- unaffected 1
- acute lymphoblastic leukemia -- blinatumomab -- chemotherapy -- propensity score analysis -- retrospective analysis 1
- acute myeloid leukemia (AML) -- internal tandem duplication of Fms‐like tyrosine kinase 3 (FLT3‐ITD) -- minimal residual disease -- omacetaxine mepesuccinate -- sorafenib 1
- acute promyelocytic leukemia -- APL -- arsenic trioxide -- ATO -- cost‐effectiveness 1
- acute promyelocytic leukemia -- all‐trans retinoic acid -- arsenic trioxide -- China -- cost‐effectiveness -- quality‐adjusted life‐year (QALY) 1
- adolescent and young adult (AYA) -- cancer -- communication -- health care communication -- physician‐patient relationship 1